MEMOIR-VLM—a multimodal vision-language model for Alzheimer's disease classification and question answering
Source check: Source checked. Not independent scientific confirmation.
Finding: On held-out ADNI subjects, the corrected encoder reported 91.3% balanced accuracy for cognitively normal versus dementia classification and 68.2% for three-class diagnosis. Zero-shot OASIS-3 evaluation reported 78.7% balanced accuracy for cognitively normal versus impaired classification (AUC 0.889) with the DTI branch masked. Subject-level held-out ADNI test set (474 subjects) and separate zero-shot OASIS-3 cohort (1,048 subjects); retrospective dataset evaluations only. The paper notes that one initial configuration leaked CDR-SB as input and reports corrected evaluation excluding it. No prospective clinical-use or outcome validation is reported.
Technology: A multimodal learned encoder combines MRI, diffusion imaging and clinical variables for multi-task diagnosis and regression; a retrieval-augmented language layer supports case-based question answering.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- A multimodal learned encoder combines MRI, diffusion imaging and clinical variables for multi-task diagnosis and regression; a retrieval-augmented language layer supports case-based question answering.
- Test and result
- On held-out ADNI subjects, the corrected encoder reported 91.3% balanced accuracy for cognitively normal versus dementia classification and 68.2% for three-class diagnosis. Zero-shot OASIS-3 evaluation reported 78.7% balanced accuracy for cognitively normal versus impaired classification (AUC 0.889) with the DTI branch masked.
- Limitation / still unknown
- Subject-level held-out ADNI test set (474 subjects) and separate zero-shot OASIS-3 cohort (1,048 subjects); retrospective dataset evaluations only. The paper notes that one initial configuration leaked CDR-SB as input and reports corrected evaluation excluding it. No prospective clinical-use or outcome validation is reported.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/computational-neuroscience/articles/10.3389/fncom.2026.1902258/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary source full text Methods and Results; version/date checked against bibliographic record..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.